P457: COMPLEX CARYOTYPE IS AN INDEPENDENT RISK FACTOR IN TP53-MUTATED AML

• Christian Rausch,
• Maja Rothenberg-Thurley,
• Annika Dufour,
• Stephanie Schneider,
• Hanna Gittinger,
• Cristina Sauerland,
• Dennis Görlich,
• Utz Krug,
• Wolfgang E. Berdel,
• Bernhard E. Woermann,
• Wolfgang Hiddemann,
• Jan Braess,
• Michael von Bergwelt-Baildon,
• Karsten Spiekermann,
• Tobias Herold,
• Klaus H. Metzeler

Affiliations

Christian Rausch

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Maja Rothenberg-Thurley

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Annika Dufour

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Stephanie Schneider

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Hanna Gittinger

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Cristina Sauerland

3 University of Münster, Institute of Biostatistics and Clinical Research, Münster, Germany

Dennis Görlich

3 University of Münster, Institute of Biostatistics and Clinical Research, Münster, Germany

Utz Krug

4 University Hospital Münster, Department of Medicine A, Münster, Germany

Wolfgang E. Berdel

4 University Hospital Münster, Department of Medicine A, Münster, Germany

Bernhard E. Woermann

5 German Society for Hematology and Oncology, Berlin, Germany

Wolfgang Hiddemann

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Jan Braess

8 Hospital Barmherzige Brüder, Department of Oncology and Hematology, Regensburg, Germany

Michael von Bergwelt-Baildon

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Karsten Spiekermann

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Tobias Herold

1 LMU Klinikum, Department of Medicine 3, Munich, Germany

Klaus H. Metzeler

9 University Hospital Leipzig, Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig, Germany